Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Aclipse Therapeutics
Aclipse Therapeutics and Cypress BioPharma Announce Agreement to Launch Phase 2 Study in Childhood Nephrotic Syndrome and Expand Renal Development Capabilities
Today 8:00 EDT
From
Aclipse Therapeutics
Via
Business Wire
Aclipse Therapeutics Expands Drug Development Pipeline with Signing of Exclusive, Worldwide License Agreement with Chong Kun Dang Pharmaceutical Corporation to Develop Potential Disease-Modifying Treatment for Gastroparesis
September 14, 2023
From
Aclipse Therapeutics
Via
Business Wire
Aclipse Therapeutics Announces $1.475 Million Award from the US Department of Defense
April 20, 2022
From
Aclipse Therapeutics
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.